S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 86 100 KRW 0.94% Market Closed
Market Cap: 1.7T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one ST Pharm Co Ltd stock under the Base Case scenario is 141 612.21 KRW. Compared to the current market price of 86 100 KRW, ST Pharm Co Ltd is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
141 612.21 KRW
Undervaluation 39%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

5.8
P/S
P/S
Price to Sales
5.8
vs History
76
vs Industry
29
Median 3Y
6.2
Median 5Y
6.8
Industry
4.1
Forward
5.4
More Details
50
P/E
P/E
Price to Earnings
50
vs History
60
vs Industry
3
Median 3Y
85.8
Median 5Y
74.7
Industry
32.7
Forward
44.2
More Details
30.5
P/OCF
P/OCF
Price to OCF
30.5
vs History
60
vs Industry
1
Median 3Y
191.4
Median 5Y
59.3
Industry
22.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
17
Median 3Y
-42.5
Median 5Y
-32.9
Industry
33.6
More Details
4.2
P/B
P/B
Price to Book Value
4.2
vs History
66
vs Industry
21
Median 3Y
4.5
Median 5Y
4.5
Industry
2.6
More Details
6.1
EV/S
EV/S
Enterprise Value to Sales
6.1
vs History
65
vs Industry
25
Median 3Y
6.5
Median 5Y
6.8
Industry
3.9
Forward
5.7
More Details
17.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
17.6
vs History
61
vs Industry
18
Median 3Y
18
Median 5Y
21.8
Industry
8.6
More Details
33.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.2
vs History
52
vs Industry
12
Median 3Y
38.5
Median 5Y
34
Industry
18.5
Forward
29.4
More Details
64.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
64.7
vs History
46
vs Industry
6
Median 3Y
77.6
Median 5Y
64.9
Industry
23.7
Forward
53
More Details
32.2
EV/OCF
EV/OCF
Enterprise Value to OCF
32.2
vs History
60
vs Industry
1
Median 3Y
201.9
Median 5Y
59.4
Industry
21.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-39.7
Median 5Y
-38.8
Industry
28.8
More Details
3
EV/IC
EV/IC
Enterprise Value to IC
3
vs History
63
vs Industry
28
Median 3Y
3.2
Median 5Y
3.3
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
ST Pharm Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
ST Pharm Co Ltd
KOSDAQ:237690
1.6T KRW 5.8 50 33.2 64.7
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.4B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.4B USD 7.8 42.5 26.7 40.1
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 29.9 22.3 25.9
US
IQVIA Holdings Inc
NYSE:IQV
35.9B USD 2.4 25.7 14.1 21.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.7 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.3 47.9 32.3 40.6
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.